Good afternoon. Thank you for standing by. Welcome to Oracle's fourth quarter 2022 conference call. It's now my pleasure to hand today's conference over to Oracle's senior vice president, Ken Bond.
During the preclinical stage, the focus of forecasting is not necessarily on the product itself, but on the broader opportunity within the disease area. At this point, there is limited information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results